PortfoliosLab logoPortfoliosLab logo
NRG vs. ATRA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NRG vs. ATRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NRG Energy, Inc. (NRG) and Atara Biotherapeutics, Inc. (ATRA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NRG achieves a -20.72% return, which is significantly higher than ATRA's -42.45% return. Over the past 10 years, NRG has outperformed ATRA with an annualized return of 26.90%, while ATRA has yielded a comparatively lower -31.94% annualized return.


NRG

1D
1.43%
1M
-4.28%
YTD
-20.72%
6M
-21.80%
1Y
-15.96%
3Y*
57.21%
5Y*
30.96%
10Y*
26.90%

ATRA

1D
-0.48%
1M
-0.67%
YTD
-42.45%
6M
-42.15%
1Y
19.52%
3Y*
-42.05%
5Y*
-50.77%
10Y*
-31.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NRG vs. ATRA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NRG
NRG Energy, Inc.
-20.72%78.91%78.58%69.36%-23.47%18.54%-2.14%0.69%39.59%133.69%
ATRA
Atara Biotherapeutics, Inc.
-42.45%35.91%3.82%-84.37%-79.19%-19.71%19.19%-52.59%91.93%27.46%

Correlation

The correlation between NRG and ATRA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Oct 16, 2014

0.17

Fundamentals

Market Cap

NRG:

$26.10B

ATRA:

$146.58M

EPS

NRG:

$1.21

ATRA:

-$0.72

PS Ratio

NRG:

0.76

ATRA:

6.06

Total Revenue (TTM)

NRG:

$32.38B

ATRA:

$22.62M

Gross Profit (TTM)

NRG:

$4.69B

ATRA:

$21.73M

EBITDA (TTM)

NRG:

$2.57B

ATRA:

-$6.92M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NRG vs. ATRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NRG
NRG Risk / Return Rank: 2525
Overall Rank
NRG Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
NRG Sortino Ratio Rank: 2727
Sortino Ratio Rank
NRG Omega Ratio Rank: 2727
Omega Ratio Rank
NRG Calmar Ratio Rank: 2727
Calmar Ratio Rank
NRG Martin Ratio Rank: 1717
Martin Ratio Rank

ATRA
ATRA Risk / Return Rank: 5656
Overall Rank
ATRA Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
ATRA Sortino Ratio Rank: 6565
Sortino Ratio Rank
ATRA Omega Ratio Rank: 7070
Omega Ratio Rank
ATRA Calmar Ratio Rank: 4949
Calmar Ratio Rank
ATRA Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NRG vs. ATRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NRG Energy, Inc. (NRG) and Atara Biotherapeutics, Inc. (ATRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NRGATRADifference
Sharpe ratioReturn per unit of total volatility

-0.49

Sortino ratioReturn per unit of downside risk

-1.59

Omega ratioGain probability vs. loss probability

0.97

1.22

-0.24

Calmar ratioReturn relative to maximum drawdown

-0.47

0.25

-0.72

Martin ratioReturn relative to average drawdown

-1.16

0.44

-1.61

NRG vs. ATRA - Sharpe Ratio Comparison

The current NRG Sharpe Ratio is -0.36, which is lower than the ATRA Sharpe Ratio of 0.14. The chart below compares the historical Sharpe Ratios of NRG and ATRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NRG vs. ATRA - Drawdown Comparison

The maximum NRG drawdown since its inception was -79.41%, smaller than the maximum ATRA drawdown of -99.74%. Use the drawdown chart below to compare losses from any high point for NRG and ATRA.


Loading charts...

Drawdown Indicators


NRGATRADifference

Max Drawdown

Largest peak-to-trough decline

-79.41%

-99.74%

+20.33%

Max Drawdown (1Y)

Largest decline over 1 year

-34.24%

-76.89%

+42.65%

Max Drawdown (3Y)

Largest decline over 3 years

-34.24%

-92.76%

+58.52%

Max Drawdown (5Y)

Largest decline over 5 years

-34.24%

-99.16%

+64.92%

Max Drawdown (10Y)

Largest decline over 10 years

-48.76%

-99.68%

+50.92%

Current Drawdown

Current decline from peak

-31.61%

-99.35%

+67.74%

Average Drawdown

Average peak-to-trough decline

-27.99%

-74.03%

+46.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.73%

44.08%

-30.35%

Volatility

NRG vs. ATRA - Volatility Comparison

The current volatility for NRG Energy, Inc. (NRG) is 15.26%, while Atara Biotherapeutics, Inc. (ATRA) has a volatility of 21.61%. This indicates that NRG experiences smaller price fluctuations and is considered to be less risky than ATRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NRGATRADifference

Volatility (1M)

Calculated over the trailing 1-month period

15.26%

21.61%

-6.35%

Volatility (6M)

Calculated over the trailing 6-month period

35.10%

131.62%

-96.52%

Volatility (1Y)

Calculated over the trailing 1-year period

44.88%

143.90%

-99.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.03%

121.99%

-81.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.16%

100.19%

-61.03%

Dividends

NRG vs. ATRA - Dividend Comparison

NRG's dividend yield for the trailing twelve months is around 1.46%, while ATRA has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ATRA
Atara Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NRG
NRG Energy, Inc.
1.46%1.11%1.81%2.92%4.40%3.02%3.20%0.30%0.30%0.42%1.92%4.93%

Financials

NRG vs. ATRA - Financials Comparison

This section allows you to compare key financial metrics between NRG Energy, Inc. and Atara Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B20222023202420252026
10.26B
0
(NRG) Total Revenue
(ATRA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NRG and ATRA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ATRA has higher volatility (21.61%) compared to NRG (15.26%). In terms of maximum drawdown, NRG dropped -79.41% vs ATRA's -99.74%.

ATRA currently has the higher Sharpe Ratio (0.14 vs -0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NRG and ATRA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer